Local Institution - 0241

Ulm 89081

1 studies enrolling now · 2 studies all time

What they study most

Acute Ischemic Stroke, Non-Small Cell Lung Cancer, Transient Ischemic Attack (TIA)

Studies at this site

• Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) — Recruiting now
• A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel — Completed